India, July 7 -- Isomorphic Labs, a drug discovery company spun out of Google DeepMind, is about to make a historic breakthrough in medicine. The company is gearing up to begin human clinical trials for drugs designed with the help of Artificial Intelligence. If this goes as planned, it will be a significant milestone in pharmaceutical research.

DeepMind's revolutionary AlphaFold AI system gave birth to Isomorphic Labs, which can accurately predict the structure of proteins. This AI has become so advanced that it can model how proteins interact with other molecules, such as DNA and drugs. It enables researchers to design medicines quickly and with high precision.

According to Colin Murdoch, president of Isomorphic Labs and DeepMind's ch...